Charles E. Welander
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment 14
- Obstetrics and Gynecology top 2%
- Endometrial and Cervical Cancer Treatments 7
-
- Cytokine Signaling Pathways and Interactions 3
-
- Intraperitoneal and Appendiceal Malignancies 4
-
- Monoclonal and Polyclonal Antibodies Research 5
-
- Lymphoma Diagnosis and Treatment 4
-
- Glycosylation and Glycoproteins Research 2
-
- Multiple Myeloma Research and Treatments 2
Charles E. Welander
35 papers receiving 808 citations
Peers
Comparison fields: 5 of 83
- Reproductive Medicine 358
- Obstetrics and Gynecology 248
- Oncology 192
- Immunology 117
- Surgery 195
Countries citing papers authored by Charles E. Welander
This map shows the geographic impact of Charles E. Welander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Welander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Welander more than expected).
Fields of papers citing papers by Charles E. Welander
This network shows the impact of papers produced by Charles E. Welander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Welander. The network helps show where Charles E. Welander may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charles E. Welander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 5 | |
| 2 | 1993 | 1 | |
| 3 | 1992 | 143 | |
| 4 | 1991 | 5 | |
| 5 | 1991 | 1 | |
| 6 | 1990 | 31 | |
| 7 | 1990 | 32 | |
| 8 | 1990 | 30 | |
| 9 | 1989 | 8 | |
| 10 | 1989 | 3 | |
| 11 | 1989 | 20 | |
| 12 | 1989 | 85 | |
| 13 | 1988 | 30 | |
| 14 | 1988 | 3 | |
| 15 | Interferon in the treatment of ovarian cancer. | 1988 | 6 |
| 16 | 1988 | 3 | |
| 17 | 1987 | 22 | |
| 18 | Direct and indirect effects of human recombinant gamma-interferon on tumor cells in a clonogenic assay. | 1986 | 50 |
| 19 | 1985 | 3 | |
| 20 | 1985 | 9 |
About Charles E. Welander
Charles E. Welander is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Immunology, Biophysics and Pathology and Forensic Medicine, having authored 36 papers that have together received 861 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (14 papers), Endometrial and Cervical Cancer Treatments (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Intraperitoneal and Appendiceal Malignancies (4 papers), Lymphoma Diagnosis and Treatment (4 papers), Cytokine Signaling Pathways and Interactions (3 papers), Glycosylation and Glycoproteins Research (2 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Reproductive Medicine (358 citations), Obstetrics and Gynecology (248 citations), Oncology (192 citations), Immunology (117 citations) and Surgery (195 citations). Charles E. Welander has collaborated with scholars based in United States. Frequent co-authors include Camran Nezhat, Howard D. Homesley, Farr Nezhat, Michael E. Berens, Benedict B. Benigno, Timothy M. Morgan, Paul P. Trotta, Robert J. Spiegel, Toshiaki Saito and Kim R. Geisinger. Their work appears in journals such as American Journal of Obstetrics and Gynecology, Gynecologic Oncology, Cancer, The Journal of Urology and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.